Search

Yan Bo Zou

from Philadelphia, PA
Age ~49
Get Report
Also known as:
Yan B Zou, Bo Zou Yan, Yan-Bo Zou, Zou Yan
Phone and address:
2102 Brighton St, Philadelphia, PA 19149
(646) 789-3967
Related to:
Zou X Pin, 68Zhe Zou, 54Xiuqing Zou, 39Jin Z Tian, 46Qing Zou, 51
Connected to:
Charles C Zou, 33Christopher Zou, 33Emma Zou, 72Guang Y Zou, 34Guangzhou Zou, 65Hayden J Zou, 51Jiawei Zou, 31Jim L Zou, 86Jing Q Zou, 51Jingxia Zou, 45

Yan Zou Phones & Addresses

  • 2102 Brighton St, Philadelphia, PA 19149 (646) 789-3967
  • Phila, PA
  • Boston, MA
  • Janesville, WI
  • Jersey City, NJ
  • New York, NY
  • Brooklyn, NY

Work

Company: Department of pharmacokinetics - Kenilworth, NJ May 2008 Position: Associate principal scientist

Education

School / High School: University of California at Riverside- Riverside, CA Sep 2002 Specialities: Ph.D. in bioanalytical chemistry

Resumes

Resumes

Yan Zou Photo 1

Research Scientist At Bristol-Myers Squibb Medical Imaging

View page
Location:
Greater Philadelphia Area
Industry:
Pharmaceuticals
Yan Zou Photo 2

Yan Zou

View page
Location:
United States
Yan Zou Photo 3

Yan Zou

View page
Location:
United States
Yan Zou Photo 4

Yan Zou Lincoln Park, NJ

View page
Work:
Department of Pharmacokinetics
Kenilworth, NJ
May 2008 to Nov 2013
Associate Principal Scientist
Department of Drug Metabolism and Pharmacokinetics, Merck Research Laboratories
West Point, PA
Apr 2007 to May 2008
Senior Research Chemist
University of California
Riverside, CA
Sep 2002 to Mar 2007
Research Assistant
Fudan University

Jul 2000 to Jul 2002
Research Assistant
Education:
University of California at Riverside
Riverside, CA
Sep 2002 to Mar 2007
Ph.D. in bioanalytical chemistry
Fudan University
Sep 1999 to Jul 2002
M.S. in Physical Chemistry
Fudan University
Sep 1995 to Jul 1999
B.S. in Chemistry

Business Records

Name / Title
Company / Classification
Phones & Addresses
Yan F. Zou
Principal
Chimerica Trading Corp
Whol Nondurable Goods
660 50 St, Brooklyn, NY 11220

Publications

Us Patents

Phenylglycinamide Derivatives Useful As Anticoagulants

View page
US Patent:
7622585, Nov 24, 2009
Filed:
Jan 9, 2006
Appl. No.:
11/328479
Inventors:
Xiaojun Zhang - Furlong PA, US
Eldon Scott Priestley - Yardley PA, US
Alexandra A. Nirschl - Yardley PA, US
Yan Zou - Levittown PA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 215/38
US Classification:
546148, 546146
Abstract:
The present invention relates generally to phenylglycinamide derivatives that inhibit serine proteases. In particular it0 is directed to novel phenylglycinamide derivatives, and analogues thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.

Bicyclic Modulators Of Androgen Receptor Function

View page
US Patent:
7625923, Dec 1, 2009
Filed:
Mar 2, 2005
Appl. No.:
11/070808
Inventors:
Alexandra Nirschl - Yardley PA, US
James C. Sutton - Princeton Junction NJ, US
Lawrence Hamann - Cherry Hill NJ, US
Tammy Wang - Lawrenceville NJ, US
Yan Zou - Levittown PA, US
Chongqing Sun - East Windsor NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31/4745
C07D 491/02
US Classification:
514301, 514302, 514367, 514375, 546114, 546115, 548153, 548217, 5483027
Abstract:
The present invention relates to bicyclic compounds according to formula I, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of androgen receptor-associated conditions, such as age-related diseases, for example sarcopenia,.

Phenylglycinamide And Pyridylglycinamide Derivatives Useful As Anticoagulants

View page
US Patent:
20070003539, Jan 4, 2007
Filed:
Jun 22, 2006
Appl. No.:
11/472845
Inventors:
Xiaojun Zhang - Furlong PA, US
Alexandra Nirschl - Yardley PA, US
Yan Zou - Levittown PA, US
Eldon Priestley - Yardley PA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 38/48
US Classification:
424094640
Abstract:
The present invention provides novel phenylglycinamide derivatives of Formula (I) or (IV): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables W, W, Y, Z, R, R, R, and Rare as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.

Phthalazinones And Isoquinolinones As Rock Inhibitors

View page
US Patent:
20180162823, Jun 14, 2018
Filed:
Feb 7, 2018
Appl. No.:
15/890436
Inventors:
- Princeton NJ, US
Yan Zou - Jamison PA, US
Mimi L. Quan - Yardley PA, US
Vladimir Ladziata - Ewing NJ, US
International Classification:
C07D 237/32
C07D 405/10
C07D 217/24
C07D 417/14
C07D 417/12
C07D 413/12
C07D 405/12
C07D 403/12
C07D 403/10
C07D 401/12
C07D 401/10
C07D 491/048
C07D 487/04
C07D 471/04
C07D 417/10
C07D 413/10
C07D 513/04
Abstract:
The present invention provides compounds of Formula (I):or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.

Phthalazinones And Isoquinolinones As Rock Inhibitors

View page
US Patent:
20160090364, Mar 31, 2016
Filed:
Dec 8, 2015
Appl. No.:
14/962923
Inventors:
- Princeton NJ, US
Yan Zou - Jamison PA, US
Mimi L. Quan - Yardley PA, US
International Classification:
C07D 237/32
C07D 401/10
C07D 413/12
C07D 513/04
C07D 403/12
C07D 417/12
C07D 405/12
C07D 417/14
C07D 403/10
C07D 401/12
Abstract:
The present invention provides compounds of Formula (I):or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.

Phthalazinones And Isoquinolinones As Rock Inhibitors

View page
US Patent:
20150353505, Dec 10, 2015
Filed:
Jan 17, 2014
Appl. No.:
14/759495
Inventors:
- Princeton NJ, US
Yan Zou - Jamison PA, US
Miami L. Quan - Yardley PA, US
Vladimir Ladziata - Ewing NJ, US
International Classification:
C07D 237/32
C07D 401/10
C07D 413/10
C07D 405/10
C07D 417/10
C07D 487/04
C07D 513/04
C07D 403/12
C07D 413/12
C07D 417/12
C07D 471/04
C07D 403/10
C07D 417/14
Abstract:
The present invention provides compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.

Phthalazinones And Isoquinolinones As Rock Inhibitors

View page
US Patent:
20140206686, Jul 24, 2014
Filed:
Jan 17, 2014
Appl. No.:
14/157564
Inventors:
- Princeton NJ, US
Yan Zou - Jamison PA, US
Mimi L. Quan - Yardley PA, US
International Classification:
C07D 237/32
C07D 401/10
C07D 401/12
C07D 513/04
C07D 403/12
C07D 417/12
C07D 405/12
C07D 417/14
C07D 403/10
C07D 413/12
US Classification:
5142345, 544237, 514248, 546141, 514309, 544119, 435184
Abstract:
The present invention provides compounds of Formula (I):or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.
Control profile
Yan Bo Zou from Philadelphia, PA, age ~49 Get Report